ISSN: 0008-543X

Cancer Q1 Unclaimed

John Wiley and Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 292. Journal with a Single blind Peer Review review system, and It has a price of 2500 €. The scope of the journal is focused on Cancer, Medicine, Oncology, Cancer statistics, Cancer Diagnosis. It has an SJR impact factor of 3,065 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

2500 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

3,065

SJR Impact factor

292

H Index

606

Total Docs (Last Year)

1822

Total Docs (3 years)

18396

Total Refs

8605

Total Cites (3 years)

1358

Citable Docs (3 years)

5,99

Cites/Doc (2 years)

30,36

Ref/Doc

Aims and Scope

Cancer Medicine Oncology Cancer statistics Cancer Diagnosis

Other journals with similar parameters

Nature Reviews Clinical Oncology Q1
CA - A Cancer Journal for Clinicians Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of the National Cancer Institute Q1

Best articles

2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome

A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

A pilot study of rituximab in patients with recurrent, classic Hodgkin disease

Adenosquamous carcinoma of the pancreas

Advance directives in the intensive care unit of a tertiary cancer center

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

Aspergillus sinusitis in cancer patients

Author reply

Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

Cancer-related fatigue and its impact on functioning

SHOW MORE ARTICLES

Cell-mediated immunity to varicella zoster virus in children being treated for cancer

Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data

Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients

Cognitive behavior therapy for people with cancer

Combined antineoplastic and antiretroviral therapy for patients with hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients

Comparative molecular analysis of loss of heterozygosity in adenocarcinoma in bile duct brushings and corresponding surgical pathology specimens

Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples

Comparison of psychosocial adaptation and sexual function of survivors of advanced hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD

Coronary artery disease mortality in patients treated for hodgkin's disease

Correlation of bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes

Cyproterone acetate--mechanism of action and clinical effectiveness in prostate cancer treatment

Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.